Fudan University

BEST Inc. Announces Changes to its Board of Directors

Retrieved on: 
Wednesday, May 24, 2023
Columbia University, International Finance Corporation, Culture, China International Capital Corporation, MIT Blackjack Team, MBA, CDH, NYSE, World Bank Group, Fudan University, Ecosystem, Annual report, Management, Ali Baba

Mr. Wan has confirmed that he has no disagreement with the Company's board of directors (the "Board") and there is no other matter relating to his resignation that needs to be brought to the attention of the Company's shareholders.

Key Points: 
  • Mr. Wan has confirmed that he has no disagreement with the Company's board of directors (the "Board") and there is no other matter relating to his resignation that needs to be brought to the attention of the Company's shareholders.
  • Prior to his resignation, Mr. Wan served as a member of the compensation committee, and as a member of the corporate governance and nominating committee, of the Board.
  • "We wish him the best of success in his future endeavors."
  • These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements.

ZTO Announces Change to Board Composition

Retrieved on: 
Wednesday, May 17, 2023
Cayman, University, University of Michigan, Investment, Deutsche Bank, Ross School of Business, Business, MBA, Public Interest Declassification Board, China International Capital Corporation, Alibaba Group, HKEX, Fudan University, NYSE, Economics, Rare-earth element, Cryptocurrency, Management

SHANGHAI, May 17, 2023 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and HKEX: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Company"), today announced that the board of directors of the Company (the "Board") has appointed Mr. Xudong Chen as a director of the Company, effective June 15, 2023.

Key Points: 
  • SHANGHAI, May 17, 2023 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and HKEX: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Company"), today announced that the board of directors of the Company (the "Board") has appointed Mr. Xudong Chen as a director of the Company, effective June 15, 2023.
  • Mr. Zheng Liu has tendered his resignation as a director of the Company, effective June 15, 2023.
  • From November 2019 to April 2023, Mr. Chen was a Director for Strategic Investment at Cainiao Network.
  • From July 2006 to October 2008, Mr. Chen worked at investment banking department of China International Capital Corporation as an analyst.

Kanazawa University research: Experiments reveal chilli-sensitive molecular structure fluctuation changes in TRPV1

Retrieved on: 
Tuesday, May 9, 2023
Nobel Prize, National academy, 2021 Nobel Prize in Physiology or Medicine, PNAS, Transience, Ligand, TRPV1, Howard Hughes Medical Institute, Capsaicin, Temperature, Noetics, Pain, Fudan University, Literature, Protein, Thermodynamics, Nervous system, Science, AFM, Physiology, Kanazawa University, Microscope, Fine chemical

However, the mechanisms behind the function of TRPV1 have not been clear.

Key Points: 
  • However, the mechanisms behind the function of TRPV1 have not been clear.
  • Now Ayumi Sumino at Kanazawa University in Japan and Motoyuki Hattori at the Fudan University in China and their colleagues provide important insights into this mechanism.
  • Once activated, the TRPV1 channel opens, allowing ions to permeate and signalling to the nervous system that a noxious stimulant is present.
  • Antithetic effects of agonists and antagonists on the structural fluctuations of TRPV1 channel, Proceedings of the National Academy of Sciences May 8, 2023.

Kanazawa University research: Experiments reveal chilli-sensitive molecular structure fluctuation changes in TRPV1

Retrieved on: 
Tuesday, May 9, 2023
Nobel Prize, National academy, 2021 Nobel Prize in Physiology or Medicine, PNAS, Transience, Ligand, TRPV1, Howard Hughes Medical Institute, Capsaicin, Temperature, Noetics, Pain, Fudan University, Literature, Protein, Thermodynamics, Nervous system, Science, AFM, Physiology, Kanazawa University, Microscope, Fine chemical

However, the mechanisms behind the function of TRPV1 have not been clear.

Key Points: 
  • However, the mechanisms behind the function of TRPV1 have not been clear.
  • Now Ayumi Sumino at Kanazawa University in Japan and Motoyuki Hattori at the Fudan University in China and their colleagues provide important insights into this mechanism.
  • Once activated, the TRPV1 channel opens, allowing ions to permeate and signalling to the nervous system that a noxious stimulant is present.
  • Antithetic effects of agonists and antagonists on the structural fluctuations of TRPV1 channel, Proceedings of the National Academy of Sciences May 8, 2023.

OrbusNeich Kicks Off Clinical Study of Scoreflex TRIO, Completing China's First PCI Intervention Procedure with High-Pressure, Three-wire Scoring Balloon Dilatation Catheter

Retrieved on: 
Monday, May 8, 2023
Percutaneous coronary intervention, Moyamoya disease, PTA, Calcification, Quality of life, Artery, OrbusNeich, Trial of the century, PCI, Shenzhen, Patient, National Medical Products Administration, Fudan University, Growth, Hospital, Seemabaddha, Pharmaceutical industry

This first case of success marks the beginning of the clinical study across China for obtaining the product approval.

Key Points: 
  • This first case of success marks the beginning of the clinical study across China for obtaining the product approval.
  • The principal investigator of the clinical study is the team led by Prof. Ge Junbo, Academician Zhongshan Hospital, Fudan University.
  • The clinical study on Scoreflex TRIO has officially begun now in Mainland China with the first successful trial recorded.
  • The clinical study team led by famed Academician Ge Junbo has profound professional knowledge and clinical experience, hence we are confident of speeding up the study.

The 3rd China Cultural Power Forum was held, Wei Zhang: Building a Film Powerhouse Should Satisfy the Imagination of Young Audiences

Retrieved on: 
Tuesday, May 2, 2023
Film & Motion Pictures, Entertainment, Fantasy, Communication University of China, Avatar: The Way of Water, Avatar, Communication, Gen, Athena, Culture, Teaching, Eye, ChatGPT, Journalism, Humanities, Multimedia, Emotion, Suzume, Prejudice, Medill School of Journalism, Language, Generation Z, Hamlet (place), Science, Civilization, Les Misérables, Hulk, Student, Millennials, Love, Television, Water, School, Fudan University, ONLINE, Center for Global Communication Studies, Shoe, Imagination, Conference, Housing and Building National Research Center, Film industry, Transformers

Fei Tan, director of Aollywood Film Critics Association and founder of "Si Wei Du Shu", was the academic moderator in the forum.

Key Points: 
  • Fei Tan, director of Aollywood Film Critics Association and founder of "Si Wei Du Shu", was the academic moderator in the forum.
  • From this point of view, constructing a film powerhouse should also take into account the imagination of Millennial and Gen Z audience of Chinese films.
  • Yuqing Zhu, the founder of ONLINE FILM MARKET and the director of the China Film Foundation Film Investment and Financing Development Special Fund, said that a film powerhouse is an important element of a cultural powerhouse.
  • How to retain young audiences and let young audiences continue to grow with films is a very big core issue of a film powerhouse.

From vision to reality: By going beyond agility and core to "0", CLPS facilitates financial institutions' digital transformation and application modernization

Retrieved on: 
Friday, April 21, 2023
Insurance, Fintech, Blockchain, Senior, Agriculture, Committee, Software, Research, Orientation, TPS, Digitalization, Cloud computing, Running, Restaurant, Fudan University, Architecture, Artificial intelligence, Digital, Ecosystem, CLPS, Microservices, Cryptocurrency, Bank, Online shopping, DevOps

Mr. Jingwei Sun, Senior Vice President of CLPS, presented an in-depth analysis of how financial institutions can leverage the power of technology for digital transformation.

Key Points: 
  • Mr. Jingwei Sun, Senior Vice President of CLPS, presented an in-depth analysis of how financial institutions can leverage the power of technology for digital transformation.
  • IT 1.0, which is implemented in physical architectures such as mainframes and midrange computers, is still prevalent in several traditional financial institutions.
  • However, most of the financial institutions today are running IT 2.0, managing projects and technologies in an agile manner under X86 architecture.
  • The agility and openness of digitally-native financial services enable financial institutions to better cope with market changes and capture opportunities.

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

Retrieved on: 
Friday, April 21, 2023
Drug development, University, CMC, Cancer, Hope, Nebraska Medicine, University of Nebraska Medical Center, Infection, Dove Medical Press, Clinical Oncology, CMO, Bayer, Medical director, Patient, Corporation, Fudan University, Motivation, Global Medical Device Nomenclature, Growth, Therapy, Shanghai Medical College, Pharmaceutical industry, Medical device, Science

SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr. Oliver Kong as Chief Medical Officer (CMO).

Key Points: 
  • SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr. Oliver Kong as Chief Medical Officer (CMO).
  • Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall corporate strategy planning and implementation.
  • Dr. Kong holds a doctor's degree from Shanghai Medical College of Fudan University and a master's degree of Science in Molecular Immunology from University of Nebraska Medical Center.
  • Before joining ImmVira, he served as Chief Medical Officer and Corporate Vice President at Qilu Pharmaceuticals, Vice President of Clinical Oncology at Hengrui Therapeutics, Senior Global Medical Leader of Global Medical Affairs at Novartis Oncology, Senior Medical Director at Celegene and Medical Director of US Medical Affairs at Bayer HealthCare Pharmaceuticals.

BioAdaptives, Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Internationally Acclaimed Health Scientist, Author and Patent Holder, Dr. Yaguang Liu

Retrieved on: 
Wednesday, April 5, 2023
University, Cancer, American Association for Cancer Research, Research, San Diego, Molecular medicine, Molecular biology, Angle, Japanese Cancer Association, Natural science, Fudan University, Episcopal conference, Combined, IND, Society, Book, Conference, Medicine, Pharmaceutical industry, Cardiovascular disease

LAS VEGAS, NV, April 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of Dr.Yaguang Liu to its Board of Directors.

Key Points: 
  • LAS VEGAS, NV, April 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today the appointment of Dr.Yaguang Liu to its Board of Directors.
  • Edward Jacobs, M.D., CEO Bioadaptives, Inc., states, “We are extremely fortunate to be joined by Dr. Yaguang Liu on our Board of Directors at this time.
  • Dr. Liu brings an extraordinary wealth of research and development experience related to natural medicines and supplements as evidenced by his many important patented discoveries and his impressive leadership activities globally.
  • patents of pure and safe natural botanicals, used for treatment of cancer and cardiovascular and other diseases.

Morrison Foerster Continues Expansion of Private Equity Capabilities in Asia with Addition of Rongjing Zhao

Retrieved on: 
Tuesday, April 4, 2023
Private equity, Chambers, New York University School of Law, University School, Morrison & Foerster, Business, Equity (finance), LL.B, LL.M, Republic, Journal, Investment, Fudan University, Mergers and acquisitions, Mofo, Tran, Security (finance), Financial services, Law

LONDON, April 3, 2023 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Rongjing Zhao, as a partner in the firm's Private Equity and Mergers & Acquisitions Groups, based out of its China offices. Zhao brings to Morrison Foerster more than 15 years of experience representing private equity firms, as well as public and private companies, in a variety of complex cross-border transactions. Zhao's addition underscores the continued expansion of the firm's leading private equity capabilities in Asia, where Morrison Foerster is ranked in Band 1 for Private Equity in the latest edition of Chambers Asia-Pacific and Tier 1 for China: Private Equity in The Legal 500 Asia Pacific 2021-2023, and across the firm's global offices. She is the fourth private equity partner to join the firm this quarter, following the additions of Steven Tran and Tabitha Saw in Singapore, and James Beach in San Francisco.

Key Points: 
  • Zhao's addition further strengthens and deepens the firm's global private equity capabilities in China, Asia, and beyond; fourth private equity partner to join since the start of 2023
    LONDON, April 3, 2023 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Rongjing Zhao , as a partner in the firm's Private Equity and Mergers & Acquisitions Groups, based out of its China offices.
  • Zhao brings to Morrison Foerster more than 15 years of experience representing private equity firms, as well as public and private companies, in a variety of complex cross-border transactions.
  • Zhao's addition underscores the continued expansion of the firm's leading private equity capabilities in Asia, where Morrison Foerster is ranked in Band 1 for Private Equity in the latest edition of Chambers Asia-Pacific and Tier 1 for China: Private Equity in The Legal 500 Asia Pacific 2021-2023, and across the firm's global offices.
  • "Rongjing is a highly sophisticated, U.S.-trained lawyer and Mandarin native speaker with extensive private equity M&A experience in China, Asia, and the U.S.," said Marcia Ellis, global co-chair of Morrison Foerster's Private Equity Group.